Clinical Trial Update: Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial update exploring the combination of radiotherapy with immunotherapy and chemotherapy for metastatic nasopharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Metastatic Nasopharyngeal Cancer | Phase 2 | Status: UNKNOWN